Publications by authors named "Alessandro Poffe"

Claim this Profile
G
GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species.
A Richard Rutter, Alessandro Poffe, Palmina Cavallini, T Gregg Davis, Jessica Schneck

J Pharmacol Exp Ther· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate.
Romano Di Fabio, Giuseppe Alvaro, Simone Braggio, Renzo Carletti, Philip A Gerrard, Alessandro Poffe

Bioorg Med Chem· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders.
Romano Di Fabio, Annalisa Pellacani, Stefania Faedo, Adelheid Roth, Laura Piccoli, Alessandro Poffe

Bioorg Med Chem Lett· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
Lee A Dawson, Zoë A Hughes, Kathryn R Starr, James D Storey, Letizia Bettelini, Alessandro Poffe

Neuropharmacology· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis